TERBUTALINE SULFATE
NDC 0115-2622, TERBUTALINE SULFATE, tablet, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 0115-2622
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075877
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0115-2622 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERBUTALINE SULFATE5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0115-2622-01 | 00115262201 | 100 TABLET in 1 BOTTLE (0115-2622-01) |
| 0115-2622-02 | 00115262202 | 500 TABLET in 1 BOTTLE (0115-2622-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/382dcebb-6e41-4335-818d-b5822e3fb884NADAC price for package 00115262201
GET /v1/drugs/nadac/00115262201
Use it
Look up 0115-2622 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0115-2622 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0115-2622. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.